RECQ1 Promotes Stress Resistance and DNA Replication Progression Through PARP1 Signaling Pathway in Glioblastoma

Glioblastoma (GBM) is the most common aggressive primary malignant brain tumor, and patients with GBM have a median survival of 20 months. Clinical therapy resistance is a challenging barrier to overcome. Tumor genome stability maintenance during DNA replication, especially the ability to respond to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Lian, Hao, Chen, Kui, Pang, Ying, Chen, Mu, Huang, Bingsong, Zhu, Lei, Xu, Siyi, Liu, Min, Zhong, Chunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350743/
https://www.ncbi.nlm.nih.gov/pubmed/34381789
http://dx.doi.org/10.3389/fcell.2021.714868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350743/
https://www.ncbi.nlm.nih.gov/pubmed/34381789
http://dx.doi.org/10.3389/fcell.2021.714868

Ejemplares similares